Currie Krysta, Evans Charity, Mansell Kerry, Perepelkin Jason, Jorgenson Derek
Rosetown Pharmasave (Currie), Rosetown.
College of Pharmacy and Nutrition (Evans, Mansell, Perepelkin, Jorgenson), University of Saskatchewan, Saskatoon, Saskatchewan.
Can Pharm J (Ott). 2019 Feb 27;152(3):193-203. doi: 10.1177/1715163519827980. eCollection 2019 May-Jun.
The Saskatchewan Medication Assessment Program (SMAP) is a publicly funded community pharmacy-based medication assessment service with limited previous evaluation. The purpose of this study was to explore community pharmacists' experiences with the SMAP.
Online, self-administered questionnaire that consisted of a combination of 53 Likert scale and free-text questions. All licensed pharmacists who were practising in a community pharmacy setting in Saskatchewan were eligible to participate.
Response rate was 20.3% ( = 228/1124). Most respondents agreed that the SMAP is achieving all of its intended purposes. For example, 89.7% agreed that the SMAP improved medication safety for patients who receive the service. Most pharmacists enjoyed performing the assessments (84.6%) and were confident in their ability to identify drug-related problems (88.3%). Pharmacists reported lack of time, patients having difficulty coming to the pharmacy and restrictive eligibility criteria as the top barriers to the SMAP. Good teamwork, employer support and personal professional commitment were the top recognized facilitators. Respondents made several suggestions to improve the SMAP in the free-text areas of the questionnaire.
Community pharmacists in Saskatchewan were positive and confident about performing medication assessments, and most agreed that the SMAP is achieving all of the intended purposes. Respondents also identified several barriers to providing SMAP services, which have resulted in specific recommendations that should be addressed to improve the program.
萨斯喀彻温省药物评估项目（SMAP）是一项由公共资金资助、基于社区药房的药物评估服务，此前评估有限。本研究的目的是探讨社区药剂师参与SMAP的经历。
采用在线自填式问卷，问卷包含53个李克特量表问题和自由文本问题。所有在萨斯喀彻温省社区药房执业的持牌药剂师均有资格参与。
回复率为20.3%（n = 228/1124）。大多数受访者认为SMAP实现了其所有预期目标。例如，89.7%的受访者认为SMAP提高了接受该服务患者的用药安全性。大多数药剂师喜欢进行评估（84.6%），并对自己识别药物相关问题的能力充满信心（88.3%）。药剂师报告称，时间不足、患者到药房困难以及资格标准限制是SMAP的主要障碍。良好的团队合作、雇主支持和个人职业承诺是最受认可的促进因素。受访者在问卷的自由文本区域提出了多项改进SMAP的建议。
萨斯喀彻温省的社区药剂师对进行药物评估持积极态度且充满信心，大多数人认为SMAP实现了所有预期目标。受访者还指出了提供SMAP服务的几个障碍，据此提出了一些具体建议，以改进该项目。
